Experimental Results

The final device offers a similar total visual field of almost 90º that the patient would normally have in the disease state. However, this field is shifted to include 42º of central vision on their diseased side! This is achieved at the expense of the periphery vision of the patient, but we hypothesize that the central field enhancement is more valuable that the lost peripheral vision.